Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paul M Trembling, Sudeep Tanwar & Geoffrey M Dusheiko. (2012) Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection. Expert Review of Anti-infective Therapy 10:3, pages 269-279.
Read now
Read now
Tabinda Burney & Geoffrey Dusheiko. (2011) Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients. Expert Review of Anti-infective Therapy 9:2, pages 151-160.
Read now
Read now
Aarthi Narayanan, Charles Bailey, Fatah Kashanchi & Kylene Kehn-Hall. (2011) Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses. Expert Opinion on Investigational Drugs 20:2, pages 239-254.
Read now
Read now
Articles from other publishers (34)
Ankush Kumar, Raj Kumar Narang & Rohit Bhatia. (2023) Recent advancements in NS5B inhibitors (2011-2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure 1293, pages 136272.
Crossref
Crossref
Amal Kumar Dhara & Amit Kumar Nayak. 2023. Viral Infections and Antiviral Therapies. Viral Infections and Antiviral Therapies
3
22
.
Erik De Clercq. (2022) FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis?. Viruses 14:4, pages 770.
Crossref
Crossref
Shujing Xu, Dang Ding, Xujie Zhang, Lin Sun, Dongwei Kang, Boshi Huang, Xinyong Liu & Peng Zhan. (2022) Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary. Molecules 27:3, pages 850.
Crossref
Crossref
Luděk Eyer, Martina Fojtíková, Radim Nencka, Ivo Rudolf, Zdeněk Hubálek & Daniel Ruzek. (2019)
Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2′-
C
-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus Infection
. Antimicrobial Agents and Chemotherapy 63:3.
Crossref
Crossref
Michaela Rumlová & Tomáš Ruml. (2018) In vitro methods for testing antiviral drugs. Biotechnology Advances 36:3, pages 557-576.
Crossref
Crossref
Sharon Melamed, Tomer Israely & Nir Paran. (2018) Challenges and Achievements in Prevention and Treatment of Smallpox. Vaccines 6:1, pages 8.
Crossref
Crossref
Hugo BonattiCosti D. SifriClara LarcherStefan SchneebergerCamille KottonChristian Geltner. (2017) Use of Cidofovir for Cytomegalovirus Disease Refractory to Ganciclovir in Solid Organ Recipients. Surgical Infections 18:2, pages 128-136.
Crossref
Crossref
Abid Qureshi, Gazaldeep Kaur & Manoj Kumar. (2016)
AVC
pred: an integrated web server for prediction and design of antiviral compounds
. Chemical Biology & Drug Design 89:1, pages 74-83.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
687
736
.
Brett W. Petersen & Inger K. Damon. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1694
1702.e3
.
Jana Mandíková, Marie Volková, Petr Pávek, Michal Česnek, Zlatko Janeba, Vladimír Kubíček & František Trejtnar. (2013) Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates. Toxicology 311:3, pages 135-146.
Crossref
Crossref
Jun Chang, Yun-Peng Hao, Xiao-Dong Hao, Hong-Fu Lu, Jian-Ming Yu & Xun Sun. (2013) Synthesis and Anti-HBV Activity of Novel 3′-N-phenylsulfonyl Docetaxel Analogs. Molecules 18:9, pages 10189-10212.
Crossref
Crossref
Rohit Singh & Robert Vince. (2012) 2-Azabicyclo[2.2.1]hept-5-en-3-one: Chemical Profile of a Versatile Synthetic Building Block and its Impact on the Development of Therapeutics. Chemical Reviews 112:8, pages 4642-4686.
Crossref
Crossref
Marcel Krepstakies, Julie Lucifora, Claus-Henning Nagel, Mirjam B. Zeisel, Barbara Holstermann, Heinrich Hohenberg, Ina Kowalski, Thomas Gutsmann, Thomas F. Baumert, Klaus Brandenburg, Joachim Hauber & Ulrike Protzer. (2012) A New Class of Synthetic Peptide Inhibitors Blocks Attachment and Entry of Human Pathogenic Viruses. The Journal of Infectious Diseases 205:11, pages 1654-1664.
Crossref
Crossref
Erik De Clercq. 2011. Antiviral Drugs. Antiviral Drugs
85
101
.
Erik De Clercq. 2011. Antiviral Drug Strategies. Antiviral Drug Strategies
1
28
.
Tuomas Karskela, Karel D. Klika & Harri Lönnberg. (2011) Synthesis of 7-substituted 3-β-D-ribofuranosyl-3H-imidazo[2,1-i]purines. Collection of Czechoslovak Chemical Communications 76:8, pages 1043-1054.
Crossref
Crossref
Mikhail S. Novikov, Robert W. BuckheitJr.Jr., Kartik Temburnikar, Anastasia L. Khandazhinskaya, Alexander V. Ivanov & Katherine L. Seley-Radtke. (2010) 1-Benzyl derivatives of 5-(arylamino)uracils as anti-HIV-1 and anti-EBV agents. Bioorganic & Medicinal Chemistry 18:23, pages 8310-8314.
Crossref
Crossref
Ly Le, Eric H. Lee, David J. Hardy, Thanh N. Truong & Klaus Schulten. (2010) Molecular Dynamics Simulations Suggest that Electrostatic Funnel Directs Binding of Tamiflu to Influenza N1 Neuraminidases. PLoS Computational Biology 6:9, pages e1000939.
Crossref
Crossref
Donald J. AbrahamErik Clercq. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
139
168
.
Montse Tuset, Ester López-Suñé, Carlos Cervera, Asunción Moreno & José M. Miró. (2010) Características de los fármacos antivíricos frente a virus del grupo herpes actualización 2009. Enfermedades Infecciosas y Microbiología Clínica 28:3, pages 199.e1-199.e33.
Crossref
Crossref
Anna Luganini, Andrea Giuliani, Giovanna Pirri, Lorena Pizzuto, Santo Landolfo & Giorgio Gribaudo. (2010) Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate. Antiviral Research 85:3, pages 532-540.
Crossref
Crossref
Anna Leisvuori, Yuichiro Aiba, Tuomas Lönnberg, Päivi Poijärvi-Virta, Laurence Blatt, Leo Beigelman & Harri Lönnberg. (2010) Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5′-monophosphates bearing a biodegradable protecting group. Organic & Biomolecular Chemistry 8:9, pages 2131.
Crossref
Crossref
Xuejun Zhu, Guoming Zhao, Xiaoping Zhou, Xiaoqian Xu, Guangqiang Xia, Zhibing Zheng, Lili Wang, Xiaohong Yang & Song Li. (2010) 2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly. Bioorganic & Medicinal Chemistry Letters 20:1, pages 299-301.
Crossref
Crossref
INGER K. DAMON. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1923
1932
.
Christine J Kubin & Scott M Hammer. 2010. Infectious Diseases. Infectious Diseases
1434
1453
.
Erik De Clercq. (2009) The history of antiretrovirals: key discoveries over the past 25 years. Reviews in Medical Virology 19:5, pages 287-299.
Crossref
Crossref
Michele M. Klingbeil & Theresa A. Shapiro. (2009) Unraveling the Secrets of Regulating Mitochondrial DNA Replication. Molecular Cell 35:4, pages 398-400.
Crossref
Crossref
Timothy Jancel & Scott R. Penzak. (2009) Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia. Seminars in Hematology 46:3, pages 230-247.
Crossref
Crossref
Erik De Clercq. (2009) Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives. Medicinal Research Reviews 29:4, pages 611-645.
Crossref
Crossref
Morgan Lawrenz, Riccardo Baron & J. Andrew McCammon. (2009) Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by Peramivir. Journal of Chemical Theory and Computation 5:4, pages 1106-1116.
Crossref
Crossref
Edith Lederman, Roque Miramontes, John Openshaw, Victoria A. Olson, Kevin L. Karem, John Marcinak, Rodrigo Panares, Wayne Staggs, Donna Allen, Stephen G. Weber, Surabhi Vora, Susan I. Gerber, Christine M. Hughes, Russell Regnery, Limone Collins, Pamela S. Diaz, Mary G. Reynolds & Inger Damon. (2009) Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: An investigation of potential fomites in the home environment. Vaccine 27:3, pages 375-377.
Crossref
Crossref
Erik De Clercq. 2009.
1
53
.